MedMij:V1.0 MP9.0.7-AddendaInhoudelijkeGegevensVV: verschil tussen versies
Regel 36: | Regel 36: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|8 dec 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 66: | Regel 66: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|tot nader order, | + | |style="background-color: white;"|tot nader order, Gebruik bekend |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Henegouwen /> | |}<section end=TA_Henegouwen /> | ||
===Verstrekkingen Henegouwen === | ===Verstrekkingen Henegouwen === | ||
Regel 81: | Regel 81: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|8 dec 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 113: | Regel 113: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Henegouwen /> | |}<section end=MVE_Henegouwen /> | ||
==Patiënt Carel C. Creiens== | ==Patiënt Carel C. Creiens== | ||
Regel 146: | Regel 146: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|29 jun 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 173: | Regel 173: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 7 dagen, 4 maal per dag 1 tablet | + | |style="background-color: white;"|gedurende 7 dagen, Gedurende 7 dagen, 4 maal per dag 1 tablet |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 179: | Regel 179: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 189: | Regel 189: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|14 feb 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 222: | Regel 222: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 232: | Regel 232: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 259: | Regel 259: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 1826 dagen, 2 maal per jaar 1 injectie | + | |style="background-color: white;"|gedurende 1826 dagen, Gedurende 5 jaar, 2 maal per jaar 1 injectie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 265: | Regel 265: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 275: | Regel 275: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|20 may 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 308: | Regel 308: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 60 dagen, 1 maal per dag een kwart tablet | + | |style="background-color: white;"|gedurende 60 dagen, Gedurende 60 dagen, 1 maal per dag een kwart tablet |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 314: | Regel 314: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 324: | Regel 324: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|20 jun 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 357: | Regel 357: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 21 dagen, 1 maal per week 15 ml | + | |style="background-color: white;"|gedurende 21 dagen, Gedurende 3 weken, 1 maal per week 15 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 363: | Regel 363: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 373: | Regel 373: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 jan 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 30 jan 2006, gedurende 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 406: | Regel 406: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- 650 | + | |style="background-color: white;"|Vanaf 30 jan 2006, gedurende 7 dagen, Vanaf T-650, gedurende 7 dagen, 2 maal per dag 1 druppel |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 412: | Regel 412: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 422: | Regel 422: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 28 jan 2007, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 455: | Regel 455: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 28 jan 2007, tot nader order, Vanaf T-287D, 2 maal per dag 5 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 461: | Regel 461: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 471: | Regel 471: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 sep 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 1 sep 2007, tot en met 28 jan 2008, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 504: | Regel 504: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf 1 sep 2007, tot en met 28 jan 2008, om 23:59, Vanaf T-287D tot en met T+149D 23:59, 2 maal per dag 2 inhalaties |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 510: | Regel 510: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 520: | Regel 520: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 553: | Regel 553: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 18 dagen, 1 maal per 3 dagen 2 pleisters | + | |style="background-color: white;"|gedurende 18 dagen, Gedurende 18 dagen, 1 maal per 3 dagen 2 pleisters |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 559: | Regel 559: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 569: | Regel 569: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 599: | Regel 599: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 30 dagen, gebruik volgens afspraak | + | |style="background-color: white;"|gedurende 30 dagen, Gedurende 30 dagen, gebruik volgens afspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 612: | Regel 612: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 6 jan 2014, tot en met 13 jan 2014, om 00:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 642: | Regel 642: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 6 jan 2014, tot en met 13 jan 2014, om 00:00, vanaf $T$ 1 week 6 stuks per dag; vanaf $T + 1wk$ 1 week 5 stuks per dag; vanaf $T + 2wk$ 1 week 4 stuks per dag; vanaf $T + 3wk$ 1 week 3 stuks per dag; vanaf $T + 4wk$ 1 week 2 stuks per dag; vanaf $T + 5wk$} 1 week 1 stuks per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Creiens /> | |}<section end=TA_Creiens /> | ||
===Verstrekkingen Creiens === | ===Verstrekkingen Creiens === | ||
Regel 657: | Regel 657: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|29 jun 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 683: | Regel 683: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 693: | Regel 693: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|14 feb 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 725: | Regel 725: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 735: | Regel 735: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 761: | Regel 761: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verbruiksduur | |colspan="4"|Verbruiksduur | ||
− | |style="background-color: white;"|5 | + | |style="background-color: white;"|5 jaar |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 774: | Regel 774: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|20 may 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 809: | Regel 809: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 819: | Regel 819: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|20 jun 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 851: | Regel 851: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 861: | Regel 861: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 jan 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 893: | Regel 893: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 903: | Regel 903: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 935: | Regel 935: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 945: | Regel 945: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 sep 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 977: | Regel 977: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 987: | Regel 987: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.019: | Regel 1.019: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.029: | Regel 1.029: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.058: | Regel 1.058: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.068: | Regel 1.068: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.097: | Regel 1.097: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Creiens /> | |}<section end=MVE_Creiens /> | ||
==Patiënt Aygül A. Direnç== | ==Patiënt Aygül A. Direnç== | ||
Regel 1.130: | Regel 1.130: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|14 jan 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 1.157: | Regel 1.157: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 50 dagen, 3x per dag 8 tot 10 eenheid | + | |style="background-color: white;"|gedurende 50 dagen, Gedurende 50 dagen, 3x per dag 8 tot 10 eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 1.163: | Regel 1.163: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.173: | Regel 1.173: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|14 jan 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.203: | Regel 1.203: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|tot nader order, 1 tot 2 maal per dag 1 tablet | + | |style="background-color: white;"|tot nader order, Gedurende 60 dagen, 1 tot 2 maal per dag 1 tablet |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 1.209: | Regel 1.209: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.219: | Regel 1.219: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.255: | Regel 1.255: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.265: | Regel 1.265: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|14 feb 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 1.298: | Regel 1.298: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 90 dagen, per 2 dagen 1 inhalatie | + | |style="background-color: white;"|gedurende 90 dagen, Gedurende 90 dagen, per 2 dagen 1 inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 1.304: | Regel 1.304: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.314: | Regel 1.314: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 1.341: | Regel 1.341: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 168 dagen, Cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | + | |style="background-color: white;"|gedurende 168 dagen, Gedurende 24 weken, Cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 1.350: | Regel 1.350: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.360: | Regel 1.360: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.390: | Regel 1.390: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|tot nader order, 1 tot 3 maal per week 1 tot 2 tabletten | + | |style="background-color: white;"|tot nader order, Gedurende 3 weken, 1 tot 3 maal per week 1 tot 2 tabletten |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 1.396: | Regel 1.396: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.406: | Regel 1.406: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 mar 2008 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 1.439: | Regel 1.439: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 60 dagen, Elke dag om 8:00, 14:00 en 20:00 uur 16IE | + | |style="background-color: white;"|gedurende 60 dagen, Gedurende 60 dagen, Elke dag om 8:00, 14:00 en 20:00 uur 16IE |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 1.445: | Regel 1.445: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.455: | Regel 1.455: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|4 apr 2008 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 4 apr 2008, om 15:48, gedurende 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.488: | Regel 1.488: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf 4 apr 2008, om 15:48, gedurende 5 dagen, Vanaf T om 15:48 uur, gedurende 5 dagen, 2 maal per dag 4 milliliter "Eerst oplossen in water, mond spoelen, daarna uitspugen" |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Aanvullende instructie | |colspan="3"|Aanvullende instructie | ||
Regel 1.500: | Regel 1.500: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.510: | Regel 1.510: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 6 jan 2014, tot en met 16 feb 2014, om 00:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.537: | Regel 1.537: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 6 jan 2014, tot en met 16 feb 2014, om 00:00, Vanaf T, gedurende 2 weken, 3 gram per dag dun aanbrengen; Vanaf T + 14 dagen, gedurende 3 weken, 2 gram per dag dun aanbrengen ; Vanaf T + 35 dagen, gedurende 6 dagen, 1 gram per dag dun aanbrengen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Aanvullende instructie | |colspan="3"|Aanvullende instructie | ||
Regel 1.543: | Regel 1.543: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.553: | Regel 1.553: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 1.580: | Regel 1.580: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 48 dagen, 2x per dag 1/4 tablet | + | |style="background-color: white;"|gedurende 48 dagen, Gedurende 48 dagen, 2x per dag 1/4 tablet |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 1.586: | Regel 1.586: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.596: | Regel 1.596: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 1.623: | Regel 1.623: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 10 dagen, DAGDOSIS: 3 stuks per dag | + | |style="background-color: white;"|gedurende 10 dagen, Gedurende 10 dagen, DAGDOSIS: 3 stuks per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Direnç /> | |}<section end=TA_Direnç /> | ||
===Verstrekkingen Direnç === | ===Verstrekkingen Direnç === | ||
Regel 1.638: | Regel 1.638: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|14 jan 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.664: | Regel 1.664: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.674: | Regel 1.674: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|14 jan 2006 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.706: | Regel 1.706: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.716: | Regel 1.716: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.745: | Regel 1.745: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.755: | Regel 1.755: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|14 feb 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.787: | Regel 1.787: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.797: | Regel 1.797: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.826: | Regel 1.826: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.836: | Regel 1.836: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.871: | Regel 1.871: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.881: | Regel 1.881: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 mar 2008 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.913: | Regel 1.913: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.923: | Regel 1.923: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|4 apr 2008 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.955: | Regel 1.955: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.965: | Regel 1.965: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.994: | Regel 1.994: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.004: | Regel 2.004: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.030: | Regel 2.030: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.040: | Regel 2.040: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 jan 2007 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.066: | Regel 2.066: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Direnç /> | |}<section end=MVE_Direnç /> | ||
==Patiënt Hanneke XXX_Bekker== | ==Patiënt Hanneke XXX_Bekker== | ||
Regel 2.099: | Regel 2.099: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 mar 2017 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.129: | Regel 2.129: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.139: | Regel 2.139: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|13 mar 2017 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 2.172: | Regel 2.172: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.182: | Regel 2.182: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|13 mar 2018 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.242: | Regel 2.242: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_XXX_Bekker /> | |}<section end=TA_XXX_Bekker /> | ||
===Verstrekkingen XXX_Bekker === | ===Verstrekkingen XXX_Bekker === | ||
Regel 2.254: | Regel 2.254: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 mar 2017 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.280: | Regel 2.280: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.290: | Regel 2.290: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|13 mar 2017 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.316: | Regel 2.316: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.326: | Regel 2.326: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|13 mar 2018 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.382: | Regel 2.382: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_XXX_Bekker /> | |}<section end=MVE_XXX_Bekker /> | ||
==Patiënt Brooke B. van der Berken== | ==Patiënt Brooke B. van der Berken== | ||
Regel 2.415: | Regel 2.415: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|24 apr 2016 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 2.445: | Regel 2.445: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 40 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | + | |style="background-color: white;"|gedurende 40 dagen, Gedurende 40 dagen, 3 maal per dag 1 Eetlepel (= 15ml) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 2.451: | Regel 2.451: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Berken /> | |}<section end=TA_Berken /> | ||
===Verstrekkingen Berken === | ===Verstrekkingen Berken === | ||
Regel 2.463: | Regel 2.463: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|24 apr 2016 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.495: | Regel 2.495: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Berken /> | |}<section end=MVE_Berken /> | ||
==Patiënt B. B. van der Sluis== | ==Patiënt B. B. van der Sluis== | ||
Regel 2.528: | Regel 2.528: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dec 2018, om 12:45 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 2.558: | Regel 2.558: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 30 dagen, 3 maal per dag 1 | + | |style="background-color: white;"|gedurende 30 dagen, Gedurende 30 dagen, 3 maal per dag 1 eetlepel (= 15ml) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 2.564: | Regel 2.564: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.574: | Regel 2.574: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 apr 2017, om 12:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 2.604: | Regel 2.604: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 30 dagen, 3 maal per dag 1 | + | |style="background-color: white;"|gedurende 30 dagen, Gedurende 30 dagen, 3 maal per dag 1 eetlepel (= 15ml) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 2.610: | Regel 2.610: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Sluis /> | |}<section end=TA_Sluis /> | ||
===Verstrekkingen Sluis === | ===Verstrekkingen Sluis === | ||
Regel 2.622: | Regel 2.622: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dec 2018, om 12:45 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.654: | Regel 2.654: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.664: | Regel 2.664: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 apr 2017, om 12:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.696: | Regel 2.696: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Sluis /> | |}<section end=MVE_Sluis /> | ||
==Patiënt Peter P. Veenoord== | ==Patiënt Peter P. Veenoord== | ||
Regel 2.729: | Regel 2.729: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|4 apr 2008 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 2.762: | Regel 2.762: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 5 dagen, 4 maal per dag 2 milliliter Eerst oplossen in water, mond spoelen, daarna uitspugen | + | |style="background-color: white;"|gedurende 5 dagen, Gedurende 5 dagen, 4 maal per dag 2 milliliter "Eerst oplossen in water, mond spoelen, daarna uitspugen" |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Aanvullende instructie | |colspan="3"|Aanvullende instructie | ||
Regel 2.774: | Regel 2.774: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|5001d450-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5001d450-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Veenoord /> | |}<section end=TA_Veenoord /> | ||
===Verstrekkingen Veenoord === | ===Verstrekkingen Veenoord === | ||
Regel 2.786: | Regel 2.786: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|5001d450-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5001d450-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|4 apr 2008 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.818: | Regel 2.818: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|5001d450-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5001d450-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Veenoord /> | |}<section end=MVE_Veenoord /> | ||
==Patiënt Aaltje A. Adelaar== | ==Patiënt Aaltje A. Adelaar== | ||
Regel 2.851: | Regel 2.851: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Afspraakdatum | |colspan="4"|Afspraakdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|15 jul 2015 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
Regel 2.884: | Regel 2.884: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|gedurende 60 dagen, elke 4 dagen 2 stuks | + | |style="background-color: white;"|gedurende 60 dagen, Gedurende 60 dagen, elke 4 dagen 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 2.890: | Regel 2.890: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=TA_Adelaar /> | |}<section end=TA_Adelaar /> | ||
===Verstrekkingen Adelaar === | ===Verstrekkingen Adelaar === | ||
Regel 2.902: | Regel 2.902: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"|5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Aanschrijfdatum | |colspan="4"|Aanschrijfdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|15 jul 2015 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 2.934: | Regel 2.934: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"|5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16. | + | |style="background-color: white;"|5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|}<section end=MVE_Adelaar /> | |}<section end=MVE_Adelaar /> | ||
[[Categorie:Kwalificatie]] | [[Categorie:Kwalificatie]] |
Versie van 9 mei 2019 om 09:35
{{#customtitle:Raadplegen verstrekkingenvertaling 9.0.7: addendum inhoudelijke gegevens kwalificatie}}
Inhoud
1 Addenda voor inhoudelijke gegevens
1.1 Patiënt Richard R. van Henegouwen
Patiënt | ||
Gegevenselement | Waarde | |
Naamgegevens | Richard R. van Henegouwen | |
Identificatienummer | 555555112 [BSN] | |
Geboortedatum | 20 feb 1950 | |
Geslacht | Man (code = 'M' in codeSystem 'AdministrativeGender') |
1.1.1 Toedieningsafspraken Henegouwen
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 8 dec 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | MEBENDAZOL SAN TABLET 100MG (code = '14234785' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1046764' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '9954' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | tot nader order, Gebruik bekend | |||
MBH identificatie | 38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.1.2 Verstrekkingen Henegouwen
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 8 dec 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 2 stuks | |||
Geneesmiddel - primaire code | MEBENDAZOL SAN TABLET 100MG (code = '14234785' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1046764' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '9954' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | 38129f10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.2 Patiënt Carel C. Creiens
Patiënt | ||
Gegevenselement | Waarde | |
Naamgegevens | Carel C. Creiens | |
Identificatienummer | 999999060 [BSN] | |
Geboortedatum | 1 jun 1950 | |
Geslacht | Man (code = 'M' in codeSystem 'AdministrativeGender') |
1.2.1 Toedieningsafspraken Creiens
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 29 jun 2006 | |||
Gebruiksperiode | gedurende 7 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | VERAPAMIL HCL CF TABLET 40MG (code = '14303841' in codeSystem 'G-Standaard Artikel') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 7 dagen, Gedurende 7 dagen, 4 maal per dag 1 tablet | |||
Doseerinstructie | 4 maal per dag 1 stuk | |||
MBH identificatie | 1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 14 feb 2006 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | ORS POEDER SACHET 5,4G SAN (code = '14565277' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1417762' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Gebruiksinstructie | ||||
Omschrijving | tot nader order, 3 maal per dag 1 zakje | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
MBH identificatie | 47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 5 jan 2007 | |||
Gebruiksperiode | gedurende 1826 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | PROLIA 60 INJVLST 60MG/ML WWSP 1ML (code = '15654486' in codeSystem 'G-Standaard Artikel') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 1826 dagen, Gedurende 5 jaar, 2 maal per jaar 1 injectie | |||
Doseerinstructie | 2 maal per jaar 1 stuk | |||
MBH identificatie | 4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 20 may 2007 | |||
Gebruiksperiode | gedurende 60 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 200MG CLICKER (code = '14765233' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '719374' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '50997' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 60 dagen, Gedurende 60 dagen, 1 maal per dag een kwart tablet | |||
Doseerinstructie | 1 maal per dag 0.25 stuk | |||
MBH identificatie | 52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 20 jun 2007 | |||
Gebruiksperiode | gedurende 21 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | KENACORT A 40 INJECTIESUSPENSIE 40MG/ML FLACON 5ML (code = '12128198' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '219584' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '120219' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 21 dagen, Gedurende 3 weken, 1 maal per week 15 ml | |||
Doseerinstructie | 1 maal per week 15 ml | |||
MBH identificatie | 59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 28 jan 2006 | |||
Gebruiksperiode | Vanaf 30 jan 2006, gedurende 7 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | TRUSOPT OOGDRUPPELS 20MG/ML FLACON 5ML (code = '13906550' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '850144' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '95575' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf 30 jan 2006, gedurende 7 dagen, Vanaf T-650, gedurende 7 dagen, 2 maal per dag 1 druppel | |||
Doseerinstructie | 2 maal per dag 1 druppel | |||
MBH identificatie | 5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 28 jan 2007 | |||
Gebruiksperiode | Vanaf 28 jan 2007, tot nader order | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | RESONIUM A POEDER (code = '13650203' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '15261' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '121363' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf 28 jan 2007, tot nader order, Vanaf T-287D, 2 maal per dag 5 gram | |||
Doseerinstructie | 2 maal per dag 5 gram | |||
MBH identificatie | 63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 1 sep 2007 | |||
Gebruiksperiode | Vanaf 1 sep 2007, tot en met 28 jan 2008, om 23:59 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | SEREVENT DISKUS INHPDR 50MCG 60DO (code = '14039303' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1029746' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '87424' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf 1 sep 2007, tot en met 28 jan 2008, om 23:59, Vanaf T-287D tot en met T+149D 23:59, 2 maal per dag 2 inhalaties | |||
Doseerinstructie | 2 maal per dag 2 doses | |||
MBH identificatie | 6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 1 nov 2007 | |||
Gebruiksperiode | gedurende 18 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | DUROGESIC 100 MATRIXPLEISTER 16,8MG (code = '13878956' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '836982' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '122033' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 18 dagen, Gedurende 18 dagen, 1 maal per 3 dagen 2 pleisters | |||
Doseerinstructie | 1 maal per 3 dagen 2 stuks | |||
MBH identificatie | 6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 1 nov 2007 | |||
Gebruiksperiode | gedurende 30 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | Carvedilol CF tablet 6,25mg (code = '14933349' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | CARVEDILOL TABLET 6,25MG (code = '101451' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 30 dagen, Gedurende 30 dagen, gebruik volgens afspraak | |||
MBH identificatie | 721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 1 nov 2007 | |||
Gebruiksperiode | Vanaf 6 jan 2014, tot en met 13 jan 2014, om 00:00 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | Diazepam PCH tablet 5mg (code = '13908790' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | Diazepam tablet 5mg (code = '20664' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf 6 jan 2014, tot en met 13 jan 2014, om 00:00, vanaf $T$ 1 week 6 stuks per dag; vanaf $T + 1wk$ 1 week 5 stuks per dag; vanaf $T + 2wk$ 1 week 4 stuks per dag; vanaf $T + 3wk$ 1 week 3 stuks per dag; vanaf $T + 4wk$ 1 week 2 stuks per dag; vanaf $T + 5wk$} 1 week 1 stuks per dag | |||
MBH identificatie | 78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.2.2 Verstrekkingen Creiens
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 29 jun 2006 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | VERAPAMIL HCL CF TABLET 40MG (code = '14303841' in codeSystem 'G-Standaard Artikel') | |||
MBH identificatie | 1f5eebe0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 14 feb 2006 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | ORS POEDER SACHET 5,4G SAN (code = '14565277' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1417762' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Verbruiksduur | 10 dagen | |||
MBH identificatie | 47f39010-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 5 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 10 stuks | |||
Geneesmiddel - primaire code | PROLIA 60 INJVLST 60MG/ML WWSP 1ML (code = '15654486' in codeSystem 'G-Standaard Artikel') | |||
Verbruiksduur | 5 jaar | |||
MBH identificatie | 4d5128b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 20 may 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 6 stuks | |||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 200MG CLICKER (code = '14765233' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '719374' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '50997' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Verbruiksduur | 24 dagen | |||
MBH identificatie | 52c41e10-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 20 jun 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 10 stuks | |||
Geneesmiddel - primaire code | KENACORT A 40 INJECTIESUSPENSIE 40MG/ML FLACON 5ML (code = '12128198' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '219584' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '120219' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | 59df4530-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 28 jan 2006 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 1 stuk | |||
Geneesmiddel - primaire code | TRUSOPT OOGDRUPPELS 20MG/ML FLACON 5ML (code = '13906550' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '850144' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '95575' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | 5ed2f870-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 28 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 10 gram | |||
Geneesmiddel - primaire code | RESONIUM A POEDER (code = '13650203' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '15261' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '121363' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | 63c23ee0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 1 sep 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 10 stuks | |||
Geneesmiddel - primaire code | SEREVENT DISKUS INHPDR 50MCG 60DO (code = '14039303' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1029746' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '87424' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | 6898f440-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 1 nov 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 12 stuks | |||
Geneesmiddel - primaire code | DUROGESIC 100 MATRIXPLEISTER 16,8MG (code = '13878956' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '836982' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '122033' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | 6da7a990-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 1 nov 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | Carvedilol CF tablet 6,25mg (code = '14933349' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | CARVEDILOL TABLET 6,25MG (code = '101451' in codeSystem 'G-Standaard GPK') | |||
MBH identificatie | 721def70-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 1 nov 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 180 stuks | |||
Geneesmiddel - primaire code | Diazepam PCH tablet 5mg (code = '13908790' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | Diazepam tablet 5mg (code = '20664' in codeSystem 'G-Standaard GPK') | |||
MBH identificatie | 78074d50-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.3 Patiënt Aygül A. Direnç
Patiënt | ||
Gegevenselement | Waarde | |
Naamgegevens | Aygül A. Direnç | |
Identificatienummer | 555555914 [BSN] | |
Geboortedatum | 20 may 1950 | |
Geslacht | Man (code = 'M' in codeSystem 'AdministrativeGender') |
1.3.1 Toedieningsafspraken Direnç
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 14 jan 2006 | |||
Gebruiksperiode | gedurende 50 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '14305054' in codeSystem 'G-Standaard Artikelnummer') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 50 dagen, Gedurende 50 dagen, 3x per dag 8 tot 10 eenheid | |||
Doseerinstructie | 3 maal per dag 8 à 10 eenheid | |||
MBH identificatie | d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 14 jan 2006 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '14165635' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1110837' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '103039' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | tot nader order, Gedurende 60 dagen, 1 tot 2 maal per dag 1 tablet | |||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | |||
MBH identificatie | 9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 10 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | Cetomacrogolcreme met 10% vaseline fagron (code = '14344491' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | tot nader order, 1 tot 3 keer per dag aanbrengen | |||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem '2.16.840.1.113883.2.4.4.5') | |||
Doseerinstructie | 1 à 3 maal per dag | |||
MBH identificatie | a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 14 feb 2007 | |||
Gebruiksperiode | gedurende 90 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | SPIRIVA INHALPDR 18 MCG (code = '14750406' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1476866' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '115371' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 90 dagen, Gedurende 90 dagen, per 2 dagen 1 inhalatie | |||
Doseerinstructie | 1 maal per 2 dagen 1 dosis | |||
MBH identificatie | a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 28 jan 2007 | |||
Gebruiksperiode | gedurende 168 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | Marvelon tablet (code = '12323047' in codeSystem 'G-Standaard Artikel') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 168 dagen, Gedurende 24 weken, Cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | |||
Doseerinstructie | gedurende 21 dagen 1 maal per dag | |||
Herhaalperiode cyclisch schema | 28 dagen | |||
MBH identificatie | ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 28 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | METFORMINE HCL CF TABLET 850MG (code = '15061078' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1037137' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '15865' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | tot nader order, Gedurende 3 weken, 1 tot 3 maal per week 1 tot 2 tabletten | |||
Doseerinstructie | 1 à 3 maal per week 1 à 2 stuks | |||
MBH identificatie | b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 6 mar 2008 | |||
Gebruiksperiode | gedurende 60 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | INSULATARD PENFILL INJ 100IE/ML PATR 3ML (code = '14815982' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '709085' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '111325' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 60 dagen, Gedurende 60 dagen, Elke dag om 8:00, 14:00 en 20:00 uur 16IE | |||
Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 16 internat.eenh. | |||
MBH identificatie | b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 4 apr 2008 | |||
Gebruiksperiode | Vanaf 4 apr 2008, om 15:48, gedurende 5 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML (code = '13966383' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '888567' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '38539' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf 4 apr 2008, om 15:48, gedurende 5 dagen, Vanaf T om 15:48 uur, gedurende 5 dagen, 2 maal per dag 4 milliliter "Eerst oplossen in water, mond spoelen, daarna uitspugen" | |||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem '2.16.840.1.113883.2.4.4.5') | |||
Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69' in codeSystem '2.16.840.1.113883.2.4.4.5') | |||
Doseerinstructie | 2 maal per dag 4 ml | |||
MBH identificatie | bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 10 jan 2007 | |||
Gebruiksperiode | Vanaf 6 jan 2014, tot en met 16 feb 2014, om 00:00 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '15838234' in codeSystem 'G-Standaard Artikel') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf 6 jan 2014, tot en met 16 feb 2014, om 00:00, Vanaf T, gedurende 2 weken, 3 gram per dag dun aanbrengen; Vanaf T + 14 dagen, gedurende 3 weken, 2 gram per dag dun aanbrengen ; Vanaf T + 35 dagen, gedurende 6 dagen, 1 gram per dag dun aanbrengen | |||
Aanvullende instructie | dun aanbrengen overig (code = 'OTH' in codeSystem '2.16.840.1.113883.5.1008') | |||
MBH identificatie | c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 10 jan 2007 | |||
Gebruiksperiode | gedurende 48 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | Ibuprofen PCH tablet 600mg (code = '13550055' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 48 dagen, Gedurende 48 dagen, 2x per dag 1/4 tablet | |||
Doseerinstructie | 2 maal per dag 0.25 stuk | |||
MBH identificatie | cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 10 jan 2007 | |||
Gebruiksperiode | gedurende 10 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ TABLET MSR 50MG (code = '14279762' in codeSystem 'G-Standaard HPK') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 10 dagen, Gedurende 10 dagen, DAGDOSIS: 3 stuks per dag | |||
MBH identificatie | fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.3.2 Verstrekkingen Direnç
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 14 jan 2006 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 5 stuks | |||
Geneesmiddel - primaire code | NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '14305054' in codeSystem 'G-Standaard Artikelnummer') | |||
MBH identificatie | d4d03380-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 14 jan 2006 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 120 stuks | |||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '14165635' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1110837' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '103039' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | 9b4c3b90-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 10 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 60 gram | |||
Geneesmiddel - primaire code | Cetomacrogolcreme met 10% vaseline fagron (code = '14344491' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |||
MBH identificatie | a378f9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 14 feb 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | SPIRIVA INHALPDR 18 MCG (code = '14750406' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1476866' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '115371' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | a7e331b0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 28 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 126 stuks | |||
Geneesmiddel - primaire code | Marvelon tablet (code = '12323047' in codeSystem 'G-Standaard Artikel') | |||
Verbruiksduur | 24 weken | |||
MBH identificatie | ac8c4760-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 28 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | METFORMINE HCL CF TABLET 850MG (code = '15061078' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1037137' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '15865' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Verbruiksduur | 21 weken | |||
MBH identificatie | b1730250-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 6 mar 2008 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 1 stuk | |||
Geneesmiddel - primaire code | INSULATARD PENFILL INJ 100IE/ML PATR 3ML (code = '14815982' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '709085' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '111325' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | b6d9e9c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 4 apr 2008 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 10 stuks | |||
Geneesmiddel - primaire code | FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML (code = '13966383' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '888567' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '38539' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | bb7ee0c0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 10 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 90 gram | |||
Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '15838234' in codeSystem 'G-Standaard Artikel') | |||
Verbruiksduur | 41 dagen | |||
MBH identificatie | c635f350-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 10 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 24 stuks | |||
Geneesmiddel - primaire code | Ibuprofen PCH tablet 600mg (code = '13550055' in codeSystem 'G-Standaard HPK') | |||
MBH identificatie | cbb37000-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 10 jan 2007 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ TABLET MSR 50MG (code = '14279762' in codeSystem 'G-Standaard HPK') | |||
MBH identificatie | fbaecc50-4bec-11e5-b970-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.4 Patiënt Hanneke XXX_Bekker
Patiënt | ||
Gegevenselement | Waarde | |
Naamgegevens | Hanneke XXX_Bekker | |
Identificatienummer | 999911715 [BSN] | |
Geboortedatum | 2 aug 1964 | |
Geslacht | Vrouw (code = 'F' in codeSystem 'AdministrativeGender') |
1.4.1 Toedieningsafspraken XXX_Bekker
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 6 mar 2017 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '15401367' in codeSystem 'G-Standaard Artikelnummer') | |||
Gebruiksinstructie | ||||
Omschrijving | tot nader order, Zo nodig bij pijn, maximaal 6 stuks per dag | |||
Doseerinstructie | zo nodig bij pijn , maximaal 6 stuks per dag | |||
MBH identificatie | 14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 13 mar 2017 | |||
Gebruiksperiode | gedurende 7 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '15401367' in codeSystem 'G-Standaard Artikelnummer') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 7 dagen, Gedurende 7 dagen, 1 keer per 4 uur 1 stuk | |||
Doseerinstructie | 1 maal per 4 uur 1 stuk | |||
MBH identificatie | 13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 13 mar 2018 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - Product specificatie | ||||
Product naam | Ureum 10% in eucerine cum aqua | |||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua
Regel: Ureum 10 gr Regel: Eucerine met water creme FNA ad 100g. | |||
Ingredient | ||||
Ingredient code | UREUM (code = '15219127' in codeSystem '2.16.840.1.113883.2.4.4.8') | |||
Sterkte | 10 gram per 100 gram | |||
Ingredient | ||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem '2.16.840.1.113883.2.4.4.8') | |||
Sterkte | voldoende hoeveelheid per 100 gram | |||
Gebruiksinstructie | ||||
Omschrijving | tot nader order, Zo nodig | |||
Doseerinstructie | zo nodig | |||
MBH identificatie | a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.4.2 Verstrekkingen XXX_Bekker
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 6 mar 2017 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 20 stuks | |||
Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '15401367' in codeSystem 'G-Standaard Artikelnummer') | |||
MBH identificatie | 14606290-2dbd-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 13 mar 2017 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 40 stuks | |||
Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '15401367' in codeSystem 'G-Standaard Artikelnummer') | |||
MBH identificatie | 13438b70-2dbe-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 13 mar 2018 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 100 gram | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Ureum 10% in eucerine cum aqua | |||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua
Regel: Ureum 10 gr Regel: Eucerine met water creme FNA ad 100g. | |||
Ingredient | ||||
Ingredient code | UREUM (code = '15219127' in codeSystem '2.16.840.1.113883.2.4.4.8') | |||
Sterkte | 10 gram per 100 gram | |||
Ingredient | ||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem '2.16.840.1.113883.2.4.4.8') | |||
Sterkte | voldoende hoeveelheid per 100 gram | |||
MBH identificatie | a083ca80-5772-11e8-b566-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.5 Patiënt Brooke B. van der Berken
Patiënt | ||
Gegevenselement | Waarde | |
Naamgegevens | Brooke B. van der Berken | |
Identificatienummer | 999999059 [BSN] | |
Geboortedatum | 1 may 1950 | |
Geslacht | Vrouw (code = 'F' in codeSystem 'AdministrativeGender') |
1.5.1 Toedieningsafspraken Berken
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 24 apr 2016 | |||
Gebruiksperiode | gedurende 40 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 40 dagen, Gedurende 40 dagen, 3 maal per dag 1 Eetlepel (= 15ml) | |||
Doseerinstructie | 3 maal per dag 15 ml | |||
MBH identificatie | e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.5.2 Verstrekkingen Berken
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 24 apr 2016 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 2000 ml | |||
Geneesmiddel - primaire code | NUTRIDRINK AARDBEI NR16642 (code = '13659847' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Verbruiksduur | 44 dagen | |||
MBH identificatie | e22b15e0-100a-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.6 Patiënt B. B. van der Sluis
Patiënt | ||
Gegevenselement | Waarde | |
Naamgegevens | B. B. van der Sluis | |
Identificatienummer | 999911545 [BSN] | |
Geboortedatum | 2 aug 1964 | |
Geslacht | Vrouw (code = 'F' in codeSystem 'AdministrativeGender') |
1.6.1 Toedieningsafspraken Sluis
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 5 dec 2018, om 12:45 | |||
Gebruiksperiode | gedurende 30 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 30 dagen, Gedurende 30 dagen, 3 maal per dag 1 eetlepel (= 15ml) | |||
Doseerinstructie | 3 maal per dag 15 ml | |||
MBH identificatie | 84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 5 apr 2017, om 12:00 | |||
Gebruiksperiode | gedurende 30 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 30 dagen, Gedurende 30 dagen, 3 maal per dag 1 eetlepel (= 15ml) | |||
Doseerinstructie | 3 maal per dag 15 ml | |||
MBH identificatie | 92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.6.2 Verstrekkingen Sluis
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 5 dec 2018, om 12:45 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 800 ml | |||
Geneesmiddel - primaire code | NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Verbruiksduur | 10 dagen | |||
MBH identificatie | 84bd06a0-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 5 apr 2017, om 12:00 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 1600 ml | |||
Geneesmiddel - primaire code | NUTRIDRINK AARDBEI (code = '15132714' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '710695' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Verbruiksduur | 20 dagen | |||
MBH identificatie | 92955660-5d8a-11e7-9598-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.7 Patiënt Peter P. Veenoord
Patiënt | ||
Gegevenselement | Waarde | |
Naamgegevens | Peter P. Veenoord | |
Identificatienummer | 555555021 [BSN] | |
Geboortedatum | 20 jan 1950 | |
Geslacht | Man (code = 'M' in codeSystem 'AdministrativeGender') |
1.7.1 Toedieningsafspraken Veenoord
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 4 apr 2008 | |||
Gebruiksperiode | gedurende 5 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML (code = '13966383' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '888567' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '38539' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 5 dagen, Gedurende 5 dagen, 4 maal per dag 2 milliliter "Eerst oplossen in water, mond spoelen, daarna uitspugen" | |||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem '2.16.840.1.113883.2.4.4.5') | |||
Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69' in codeSystem '2.16.840.1.113883.2.4.4.5') | |||
Doseerinstructie | 4 maal per dag 2 ml | |||
MBH identificatie | 5001d450-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.7.2 Verstrekkingen Veenoord
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 5001d450-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 4 apr 2008 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 1 stuk | |||
Geneesmiddel - primaire code | FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML (code = '13966383' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '888567' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '38539' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | 5001d450-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.8 Patiënt Aaltje A. Adelaar
Patiënt | ||
Gegevenselement | Waarde | |
Naamgegevens | Aaltje A. Adelaar | |
Identificatienummer | 999999011 [BSN] | |
Geboortedatum | 1 jan 1950 | |
Geslacht | Vrouw (code = 'F' in codeSystem 'AdministrativeGender') |
1.8.1 Toedieningsafspraken Adelaar
Toedieningsafspraak | ||||
Gegevenselement | Waarde | |||
Afspraakdatum | 15 jul 2015 | |||
Gebruiksperiode | gedurende 60 dagen | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Geneesmiddel - primaire code | OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
Gebruiksinstructie | ||||
Omschrijving | gedurende 60 dagen, Gedurende 60 dagen, elke 4 dagen 2 stuks | |||
Doseerinstructie | 1 maal per 4 dagen 2 stuks | |||
MBH identificatie | 5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
1.8.2 Verstrekkingen Adelaar
Verstrekking | ||||
Gegevenselement | Waarde | |||
Identificatie | 5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Aanschrijfdatum | 15 jul 2015 | |||
Verstrekker | ||||
Zorgaanbieder | ||||
Zorgaanbieder identificatie nummer | 01234567 (in identificerend systeem: 2.16.528.1.1007.3.3) | |||
Organisatie naam | ||||
Verstrekte hoeveelheid | 35 stuks | |||
Geneesmiddel - primaire code | OXAZEPAM GF TABLET 10MG (code = '14243091' in codeSystem 'G-Standaard Artikel') | |||
Geneesmiddel - generiekere code | (code = '1148753' in codeSystem '2.16.840.1.113883.2.4.4.7') | |||
Geneesmiddel - generiekere code | (code = '1023' in codeSystem '2.16.840.1.113883.2.4.4.1') | |||
MBH identificatie | 5ada2a80-100b-11e5-b939-0800200c9a66 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |